ATXI
Vanguard Group’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-46,293
| Closed | -$6.83K | – | 4449 |
|
2024
Q1 | $6.83K | Hold |
46,293
| – | – | ﹤0.01% | 4437 |
|
2023
Q4 | $7.45K | Hold |
46,293
| – | – | ﹤0.01% | 4485 |
|
2023
Q3 | $32.7K | Buy |
+46,293
| New | +$32.7K | ﹤0.01% | 4457 |
|
2022
Q3 | – | Sell |
-131,569
| Closed | -$36K | – | 4612 |
|
2022
Q2 | $36K | Sell |
131,569
-321,084
| -71% | -$87.9K | ﹤0.01% | 4599 |
|
2022
Q1 | $218K | Hold |
452,653
| – | – | ﹤0.01% | 4524 |
|
2021
Q4 | $411K | Hold |
452,653
| – | – | ﹤0.01% | 4463 |
|
2021
Q3 | $675K | Buy |
452,653
+2,671
| +0.6% | +$3.98K | ﹤0.01% | 4329 |
|
2021
Q2 | $1.13M | Sell |
449,982
-248,151
| -36% | -$623K | ﹤0.01% | 4125 |
|
2021
Q1 | $4.24M | Sell |
698,133
-241,573
| -26% | -$1.47M | ﹤0.01% | 3615 |
|
2020
Q4 | $5.59M | Buy |
939,706
+295,502
| +46% | +$1.76M | ﹤0.01% | 3312 |
|
2020
Q3 | $6.98M | Buy |
644,204
+215,625
| +50% | +$2.34M | ﹤0.01% | 2979 |
|
2020
Q2 | $4.62M | Buy |
428,579
+121,036
| +39% | +$1.3M | ﹤0.01% | 3133 |
|
2020
Q1 | $2.75M | Buy |
307,543
+139,390
| +83% | +$1.25M | ﹤0.01% | 3212 |
|
2019
Q4 | $1.61M | Buy |
168,153
+30,769
| +22% | +$295K | ﹤0.01% | 3507 |
|
2019
Q3 | $819K | Buy |
137,384
+38,171
| +38% | +$228K | ﹤0.01% | 3700 |
|
2019
Q2 | $625K | Hold |
99,213
| – | – | ﹤0.01% | 3789 |
|
2019
Q1 | $471K | Buy |
99,213
+29,052
| +41% | +$138K | ﹤0.01% | 3786 |
|
2018
Q4 | $379K | Sell |
70,161
-28,180
| -29% | -$152K | ﹤0.01% | 3790 |
|
2018
Q3 | $279K | Sell |
98,341
-300
| -0.3% | -$851 | ﹤0.01% | 3954 |
|
2018
Q2 | $353K | Buy |
98,641
+3,915
| +4% | +$14K | ﹤0.01% | 3889 |
|
2018
Q1 | $427K | Buy |
94,726
+50,534
| +114% | +$228K | ﹤0.01% | 3815 |
|
2017
Q4 | $161K | Buy |
44,192
+19,652
| +80% | +$71.6K | ﹤0.01% | 3958 |
|
2017
Q3 | $136K | Buy |
+24,540
| New | +$136K | ﹤0.01% | 3965 |
|